$19.68 -0.31 (-1.55%)
11/25/2009 4:00 PM

Pharmasset, Inc. (VRUS)

CAPS Rating: 2 out of 5

A clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections.

Featured Broker Partners